TrialEuropean journal of preventive cardiology2016

Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers.

Bauke Schievink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.